We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+16.39%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.4B
AUM Growth
+$319M
Cap. Flow
-$190M
Cap. Flow %
-2.98%
Top 10 Hldgs %
23.07%
Holding
289
New
50
Increased
129
Reduced
80
Closed
21

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$43.3M
2
LBRT icon
Liberty Energy
LBRT
+$32.9M
3
DXCM icon
DexCom
DXCM
+$30.7M
4
APGE icon
Apogee Therapeutics
APGE
+$27.5M
5
MPWR icon
Monolithic Power Systems
MPWR
+$26.1M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$95.2M
2
VRNA
Verona Pharma
VRNA
+$72.7M
3
GH icon
Guardant Health
GH
+$72.5M
4
CELC icon
Celcuity
CELC
+$63.7M
5
EVH icon
Evolent Health
EVH
+$53.2M

Sector Composition

Rank Sector Weight
1 Healthcare 42.37%
2 Industrials 17.69%
3 Technology 15.85%
4 Consumer Discretionary 6.94%
5 Utilities 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRT icon
251
Copart
CPRT
$27B
$375K 0.01%
+9,496
New +$394K
MANH icon
252
Manhattan Associates
MANH
$11.2B
$346K 0.01%
1,978
+263
+15% +$48.1K
OKTA icon
253
Okta
OKTA
$24.7B
$342K 0.01%
3,913
+614
+19% +$53.6K
DT icon
254
Dynatrace
DT
$12.9B
$340K 0.01%
7,716
+1,429
+23% +$66.6K
TOL icon
255
Toll Brothers
TOL
$13.6B
$310K ﹤0.01%
+2,269
New +$308K
NTNX icon
256
Nutanix
NTNX
$16B
$305K ﹤0.01%
5,862
-605,101
-99% -$37M
EW icon
257
Edwards Lifesciences
EW
$49.6B
$298K ﹤0.01%
3,456
+255
+8% +$20.9K
BLDR icon
258
Builders FirstSource
BLDR
$7.15B
$283K ﹤0.01%
2,744
-1,839
-40% -$207K
KMX icon
259
CarMax
KMX
$8.13B
$266K ﹤0.01%
6,776
-3,364
-33% -$135K
PATK icon
260
Patrick Industries
PATK
$2.74B
$245K ﹤0.01%
+2,199
New +$231K
IDXX icon
261
Idexx Laboratories
IDXX
$44.1B
$244K ﹤0.01%
+358
New +$244K
KVUE icon
262
Kenvue
KVUE
$36.9B
$238K ﹤0.01%
13,741
-12,794
-48% -$209K
CP icon
263
Canadian Pacific Kansas City
CP
$78.1B
$237K ﹤0.01%
3,188
+239
+8% +$17.6K
FHN icon
264
First Horizon
FHN
$12.2B
$216K ﹤0.01%
9,023
-27,193
-75% -$606K
PPG icon
265
PPG Industries
PPG
$24.6B
$208K ﹤0.01%
+2,005
New +$201K
AER icon
266
AerCap
AER
$23.7B
$203K ﹤0.01%
1,411
-1,926
-58% -$255K
AUR icon
267
Aurora
AUR
$12.6B
$72.9K ﹤0.01%
+18,785
New +$86K
GERN icon
268
Geron
GERN
$828M
$20.7K ﹤0.01%
+15,428
New +$19.4K
ACAD icon
269
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-575,541
Closed -$12.3M
AKRO
270
DELISTED
Akero Therapeutics
AKRO
– –
-435,293
Closed -$20.7M
CDTX
271
DELISTED
Cidara Therapeutics
CDTX
– –
-61,081
Closed -$5.85M
CVLT icon
272
Commault Systems
CVLT
$4.88B
– –
-10,765
Closed -$2.04M
EQR icon
273
Equity Residential
EQR
$24.9B
– –
-142,293
Closed -$9.21M
EVH icon
274
Evolent Health
EVH
$348M
– –
-6,292,511
Closed -$53.2M
EXLS icon
275
EXL Service
EXLS
$5.14B
– –
-41,160
Closed -$1.81M
8 9 10
11
12

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Eventide Asset Management held 289 positions worth $6.4B, up 5.3% from $6.08B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Eventide Asset Management's Q4 2025 filing shows 50 new, 129 increased, 80 reduced and 21 closed positions. Its largest new stake was Ionis Pharmaceuticals: 575,000 shares worth $45.5M. The largest sale was Insmed, an estimated $95.2M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Industrials and Technology.

  • Eventide Asset Management's largest Q4 2025 buy was Ionis Pharmaceuticals: 575,000 shares worth $45.5M.
  • Eventide Asset Management added most to Monolithic Power Systems in Q4 2025, an estimated $26.1M increase.
  • Eventide Asset Management's biggest Q4 2025 reduction was Insmed, cutting an estimated $95.2M.
  • Eventide Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $72.7M.
  • Eventide Asset Management's ten largest holdings make up 23% of its $6.4B portfolio in Q4 2025.
  • Eventide Asset Management opened 50 new positions and closed 21 in Q4 2025.
  • Eventide Asset Management's portfolio value rose 5.3% quarter-over-quarter to $6.4B.

Based on Eventide Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.